C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4

H Wang1, P Iakova, M Wilde

  • 1Department of Pathology and Huffington Center on Aging, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

Molecular Cell
|October 31, 2001
PubMed

Insights

The transcription factor CCAAT/enhancer binding protein alpha (C/EBPalpha) inhibits cell proliferation by directly blocking cdk2 and cdk4 kinases. Loss of C/EBPalpha increases kinase activity and cell growth, demonstrating its role in growth arrest.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Background:

  • CCAAT/enhancer binding protein alpha (C/EBPalpha) is a transcription factor known to inhibit cell proliferation.
  • The precise mechanisms by which C/EBPalpha exerts its growth-inhibitory effects are not fully elucidated.
  • Cyclin-dependent kinases (CDKs) like cdk2 and cdk4 are critical regulators of the cell cycle.

Purpose of the Study:

  • To investigate the direct interaction between C/EBPalpha and cell cycle kinases.
  • To identify the specific region of C/EBPalpha responsible for growth inhibition.
  • To elucidate the role of C/EBPalpha in regulating cdk2 and cdk4 activity in liver cells.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Cell proliferation assays in cultured cells.
  • Analysis of kinase activity in C/EBPalpha knockout mouse livers.

Main Results:

  • C/EBPalpha directly interacts with cdk2 and cdk4.
  • A specific region (amino acids 175-187) of C/EBPalpha mediates the inhibition of these kinases.
  • C/EBPalpha inhibits cdk2 activity by preventing its association with cyclins.
  • Cdk4 and cdk2 activities are elevated in C/EBPalpha knockout livers, correlating with increased proliferation.

Conclusions:

  • The liver-specific transcription factor C/EBPalpha directly inhibits cell proliferation.
  • C/EBPalpha functions by directly inhibiting the kinase activity of cdk2 and cdk4.
  • This direct kinase inhibition mechanism is crucial for C/EBPalpha-mediated growth arrest.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...